Projects funded by the NCN
Development of macrocyclic peptide antagonists of the PD-1/PD-L1 pathway. Charcterization of simultaneous administration of two immunomodulating agents in antitumor response
2018/31/D/NZ7/01900
Keywords:
immunomodulating agents macrocyclic peptides immunocheckpoint
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ6_2: Clinical immunology
- ST5_16:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński, Wydział Chemii
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 5
Call: SONATA 14 - announced on 2018-09-14
Amount awarded: 1 093 600 PLN
Project start date (Y-m-d): 2019-07-05
Project end date (Y-m-d): 2024-07-04
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.